The mRNA expression of c-myc and cyclin D1 was substantially downregulated by 0.88 ± 0.06-, 0.72 ± 0.03-, 0.48 ± 0.03-, 0.90 ± 0.02-, 0.72 ± 0.04-, and 0.42 ± 0.05-fold with 100, 200, and 400 μg/mL AvL-EtOH treatment, respectively, in A549 NSCLC cells (Figure 12). The gene discussed is MYC; the disease is non-small cell lung carcinoma.